1-4 of 4
Geoff T Yarranton, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KB004, a Novel Non-Fucosylated Humaneered® Antibody, Targeting EphA3, Is Active and Well Tolerated in a Phase I/II Study of Advanced Hematologic Malignancies

Ronan T Swords, MD PhD FRCPI, FRCPath, Andrew H Wei, MBBS, PhD, Simon Durrant, MBBS, MRCS, LRCP, FRCP, FRCPat, Anjali S. Advani, MD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Ian D Lewis, MBBS, PhD, Peter L. Greenberg, MD PhD, Jorge E. Cortes, MD, Geoff T Yarranton, PhD, Jackie M. Walling, MBChB, PhD, Jeffrey E. Lancet, MD
Journal: Blood
Blood (2014) 124 (21): 3756.
https://doi.org/10.1182/blood.V124.21.3756.3756
Published: 2014
Journal Articles

Immunotherapeutic Targeting of EphA3

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Varghese Palath, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3720.
https://doi.org/10.1182/blood.V124.21.3720.3720
Published: 2014
Journal Articles

An IHC Screen for EphA3 Positive Myelofibrosis (MF) and Other Myeloproliferative Neoplasms (MPNs)

Darren Locke, PhD, Frank Lynch, PhD, Steven Bernstein, PhD, Koushan Siami-Namini, MD FCAP, Geoff T Yarranton, PhD
Journal: Blood
Blood (2014) 124 (21): 5588.
https://doi.org/10.1182/blood.V124.21.5588.5588
Published: 2014
Journal Articles

EphA3 As a Target For Monoclonal Antibody Therapy For Acute Leukemia

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5013.
https://doi.org/10.1182/blood.V122.21.5013.5013
Published: 2013